Category: Adamas wins its first FDA OK

Adamas wins its first FDA OK, setting up market launch for a reformulated Parkinson’s drug

  1. Adamas wins its first FDA OK, setting up market launch for a reformulated Parkinson’s drug  Endpoints News
  2. Mid-Morning Market Update: Markets Open Higher; Big Lots Profit Tops Estimates  Nasdaq
  3. A new Parkinson’s drug is a long-acting version of a cheap generic. Should it cost $30000 a year?  STAT
  4. Full coverage

from Business – Google News https://endpts.com/adamas-wins-its-first-fda-ok-setting-up-market-launch-for-a-reformulated-parkinsons-drug/

Advertisements

Adamas wins its first FDA OK, setting up market launch for a reformulated Parkinson’s drug

  1. Adamas wins its first FDA OK, setting up market launch for a reformulated Parkinson’s drug  Endpoints News
  2. Mid-Morning Market Update: Markets Open Higher; Big Lots Profit Tops Estimates  Nasdaq
  3. A new Parkinson’s drug is a long-acting version of a cheap generic. Should it cost $30000 a year?  STAT
  4. Full coverage

from Business – Google News https://endpts.com/adamas-wins-its-first-fda-ok-setting-up-market-launch-for-a-reformulated-parkinsons-drug/